Early test of new drug for Tough-to-Treat blood cancer halted

NCT ID NCT03836053

Summary

This was an early-stage study to find a safe and effective dose of an experimental drug called AMG 420 for people with multiple myeloma that had returned or stopped responding to at least three prior types of therapy. The trial involved 23 participants who received the drug through a continuous IV infusion for 28-day cycles. The main goals were to check for serious side effects and see if the treatment could shrink the cancer.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RELAPSED AND/OR REFRACTORY MULTIPLE MYELOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Advocate Lutheran General Hospital

    Park Ridge, Illinois, 60068, United States

  • Centre Hospitalier Universitaire Dinant Godinne - Universite Catholique de Louvain Namur

    Yvoir, 5530, Belgium

  • Centres Hospitaliers Jolimont - Hopital de Jolimont

    Haine Saint Paul - La Louviere, 7100, Belgium

  • Kantonsspital St Gallen

    Sankt Gallen, 9007, Switzerland

  • Massachusetts General Hospital

    Boston, Massachusetts, 02114, United States

  • Memorial Sloan Kettering Cancer Center

    New York, New York, 10021, United States

  • National Hospital Organization Okayama Medical Center

    Okayama, Okayama-ken, 701-1192, Japan

  • St Vincents Hospital Melbourne

    Fitzroy, VIC, Victoria, 3065, Australia

  • St Vincents Hospital Sydney

    Darlinghurst, New South Wales, 2010, Australia

  • Wake Forest Baptist Health

    Winston-Salem, North Carolina, 27157, United States

Conditions

Explore the condition pages connected to this study.